Burney Co. Increases Stock Holdings in Genpact Limited (NYSE:G)

Burney Co. boosted its stake in Genpact Limited (NYSE:GFree Report) by 242.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 130,798 shares of the business services provider’s stock after acquiring an additional 92,641 shares during the quarter. Burney Co. owned 0.07% of Genpact worth $5,618,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. American Century Companies Inc. increased its stake in Genpact by 18.2% during the 2nd quarter. American Century Companies Inc. now owns 25,557 shares of the business services provider’s stock worth $823,000 after buying an additional 3,936 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Genpact by 34.2% in the second quarter. Dimensional Fund Advisors LP now owns 3,326,054 shares of the business services provider’s stock worth $107,065,000 after acquiring an additional 847,249 shares during the last quarter. Mercer Global Advisors Inc. ADV increased its position in shares of Genpact by 18.4% during the second quarter. Mercer Global Advisors Inc. ADV now owns 50,971 shares of the business services provider’s stock worth $1,641,000 after purchasing an additional 7,911 shares in the last quarter. Amalgamated Bank raised its stake in Genpact by 1.4% in the 2nd quarter. Amalgamated Bank now owns 105,694 shares of the business services provider’s stock valued at $3,402,000 after purchasing an additional 1,497 shares during the last quarter. Finally, Vanguard Personalized Indexing Management LLC lifted its holdings in Genpact by 53.1% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 49,134 shares of the business services provider’s stock valued at $1,580,000 after purchasing an additional 17,034 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Insider Activity

In related news, CEO Balkrishan Kalra sold 9,000 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at approximately $12,407,545.60. This represents a 3.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Piyush Mehta sold 12,000 shares of the firm’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 35,058 shares of company stock valued at $1,558,675. 2.80% of the stock is currently owned by company insiders.

Genpact Price Performance

G stock opened at $44.59 on Wednesday. The business’s fifty day moving average price is $44.32 and its 200 day moving average price is $39.51. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $47.98. The company has a market capitalization of $7.86 billion, a PE ratio of 12.25, a P/E/G ratio of 1.54 and a beta of 1.18. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.

Genpact Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 23rd. Stockholders of record on Monday, December 9th were given a dividend of $0.1525 per share. The ex-dividend date was Monday, December 9th. This represents a $0.61 annualized dividend and a dividend yield of 1.37%. Genpact’s dividend payout ratio is presently 16.76%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on G. Needham & Company LLC increased their target price on shares of Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, November 11th. TD Cowen raised their price objective on shares of Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a research report on Friday, November 8th. Finally, Robert W. Baird lifted their target price on Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. Eight analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, Genpact presently has a consensus rating of “Hold” and an average target price of $42.33.

View Our Latest Report on G

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Recommended Stories

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.